- €8.60bn
- €8.49bn
- €4.07bn
Brief: Biomerieux Cuts 2025 Sales Growth Outlook To Max. 6.5%
Brief: Biomerieux H1 Net Sales At EUR 2.04 Bln
Top of the Street: Deutsche Bank, Commerzbank, UniCredit
Europe Research Roundup: Bioinvent, Diasorin, Sandoz
JPM starts bioMérieux at 'neutral', says growth prospects priced in
Europe Research Roundup: Barclays, Kingfisher, Tesco
French and Benelux stocks-Factors to watch
Brief: Biomerieux Gets U.S. FDA Clearance For Additional Swab To BIOFIRE SPOTFIRE
'Buying opportunity ahead of growth acceleration' - RBC raises DiaSorin to 'outperform'
Brief: Biomerieux Acquires Day Zero Diagnostics Solutions And Technologies
RBC cuts Biomerieux to 'sector perform' on margin risk
Europe Research Roundup: Airbus, Deutsche Telekom, L'Oreal
European shares hold losses after ECB eases borrowing rates as expected (updated)
Biomerieux drops as it warns of larger FX impact on 2025 CEBIT
Brief: Biomerieux Q1 Total Sales EUR 1.10 Billion
Europe Research Roundup: Airbus, Capgemini, Euronext
Brief: Biomerieux Obtains CE-Marking For LUMED APSS
Barclays says tariffs open doors to stock picking; initiates De' Longhi, TechnoGym
Brief: Biomerieux Receives FDA Clearance For Its Vitek Compact Pro